Somanetics Corp (NASDAQ:SMTS)
CAPS Rating:
Develops, manufactures and markets the INVOS Cerebral Oximeter, the only non-invasive patient monitoring system commercially available in the United States that continuously measures changes in the blood oxygen level in the adult brain.
RSS Headlines
Fool UK
Recs
strong margins and growth, good liquidity and a niche market in healthcare, should be stong for two years until the next best thing comes out.
Did you mean "strong" for two years? I hope so...I'm long SMTS but it hasn't gone anywhere. I am beginning to wonder whether this has been a wise purchase.